Evidence map›Paper›PMID 42431328›Full record

ArticleInternational journal of radiation oncology, biology, physics2026

Postoperative Epidural Disease and Local Control After Separation Surgery and Spine Stereotactic Body Radiation Therapy.

Christopher B Jackson, Amanda Cuastumal Aguirre, Anne S Reiner, Justin Haseltine, Boris A Mueller, Adam M Schmitt, Daniel S Higginson, Yoshiya Yamada, Assaf Moore, Max Vaynrub and 5 more

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Christopher B JacksonDepartments of Radiation Oncology. Electronic address: jacksoc2@mskcc.org.
Amanda Cuastumal AguirreNeurosurgery.
Anne S ReinerEpidemiology and Biostatistics.
Justin HaseltineDepartments of Radiation Oncology.
Boris A MuellerDepartments of Radiation Oncology.
Adam M SchmittDepartments of Radiation Oncology.
Daniel S HigginsonDepartments of Radiation Oncology.
Yoshiya YamadaDepartments of Radiation Oncology.
Assaf MooreDepartments of Radiation Oncology.
Max VaynrubOrthopedic Surgery.
Rabih Bou NassifNeurosurgery.
W Christopher NewmanNeurosurgery.
Eric LisRadiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Mark H BilskyNeurosurgery.
Ori BarzilaiNeurosurgery.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeLimited data are available on outcomes of patients with spinal metastases treated with separation surgery with postoperative stereotactic body radiation therapy. METHODS AND MATERIALS: This is a retrospective cohort study of 497 patients treated for 532 lesions between 2013 and 2024. We evaluated local failure (LF) and adverse events (hardware failure [HF] requiring surgical intervention, radiation myelitis [RM], and vertebral compression fracture [VCF]). Incidences of LF, VCF, RM, and HF were analyzed considering death as a competing risk. Dosimetric variables, including minimal biologically effective dose (BED) to the clinical target volume (CTV Dmin BED10), were obtained. Preoperative and postoperative epidural spinal cord compression (ESCC) scores were calculated based on preoperative magnetic resonance imaging and postoperative myelogram simulation.

resultsMedian follow-up time among surviving patients was 74.5 months (95% CI, 70-94). Median overall survival was 14 months (95% CI, 13-17). The risk of LF (95% CI) at 1, 2, and 3 years was 7.7% (5.6%-10%), 10% (7.9%-13%), and 13% (10%-16%), respectively. At 2 years, cumulative incidences of VCF, RM, and HF requiring surgery were 2% (95% CI, 1%-3.5%), 1% (0.39%-2.3%), and 3.8% (2.4%-5.8%), respectively. On univariable and multivariable regression, CTV Dmin BED10 correlated with risk of LF (on multivariable regression, hazard ratio, 0.96; 95% CI, 0.93-0.99; P = .005). After excluding previously radiated lesions, postoperative ESCC ≤1C was associated with an approximately 2-times higher likelihood of achieving the median CTV Dmin BED10 than ESCC 2 (odds ratio, 2.06; 95% CI, 1.31-3.26; P = .002), whereas a postoperative ESCC ≤1B was not associated with higher odds of achieving the median CTV Dmin BED10 compared with ≥1C (odds ratio, 0.75; 95% CI, 0.50-1.11; P = .15).

conclusionsIn this large series of separation surgery followed by spine stereotactic body radiation therapy, local control was excellent with few adverse events. Higher CTV minimum biological dose-enabled by postoperative ESCC ≤1C-was the strongest predictor of durable local control.

Identifiers

PMID42431328
PMCPMC13618439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.